South Africa is currently bracing for the most significant paradigm shift in its HIV response in over a decade. The national health authority has officially approved long-acting injectable pre-exposure prophylaxis (PrEP). There are plans to roll it out across the public sector in the coming year. For public health advocates, this development represents a potential turning point for prevention. It…